Cryonics Questions and Choices
MHP-2 is a cryopreservation perfusate. In plain terms, it is a prepared fluid used to wash blood out and replace it before long cold transport and later preservation.
That sounds technical, but the idea is simple. The fluid is meant to keep tissue from clotting, swelling, and losing flow when the body has already been declared dead and cryonics procedures begin.
What MHP-2 actually is
MHP-2 is a formula, not a vague label. It is a specific mix of sugars, salts, buffers, proteins, and other additives designed for cryonics blood substitution.
Its core job is to make cold circulation less damaging. It does that by pushing oxygen-poor blood out, slowing clotting, and helping the brain and other tissues tolerate the cold period before later cryoprotectant steps.
The solution includes mannitol, bicarbonate, potassium and calcium salts, magnesium, glucose, glutathione, hydroxyethyl starch, heparin, and insulin. Some versions also track adenine and ribose in the mix.
The exact recipe matters because tiny preparation errors can change how the solution behaves. In this setting, a small mistake is not small at all.
Why this solution matters
People often think cryonics is only about freezing or storage. That is not where the real problem starts.
The early danger is the transition. After legal death, the body still contains blood, heat, acid buildup, and fragile vessels. If circulation is not managed carefully, the tissue can suffer more damage before preservation even begins.
That is where MHP-2 comes in. It is used during blood washout and cold transport to reduce clotting and help cooling happen in a more controlled way.
This part matters because the brain is especially sensitive to poor flow. If blood sits too long or moves badly, later perfusion becomes harder.
The part people usually miss
The common confusion is this: MHP-2 is not the same thing as cryoprotectant. It is not the final vitrification fluid.
It is a bridge fluid. It sits in the middle of the process, between blood and later preservation chemistry.
That middle stage is easy to underestimate. Yet it can shape everything that follows. If the washout goes badly, later perfusion can be less effective. If it goes well, the next steps have a better chance of working as intended.
This is why cryonics teams treat MHP-2 as a practical tool, not a symbolic one. The goal is not elegance. The goal is flow.
What the formula is trying to do
MHP-2 is built to work in cold conditions. It is hyperosmolar, which means it has more dissolved material than normal blood. That helps limit swelling in tissues.
It also includes buffering agents to keep pH in a safer range. In cryonics practice, the target has often been around pH 8.0 to 8.2, not the neutral 7.4 many people expect from body fluids.
That higher pH can surprise readers. It is not there to imitate normal blood. It is there because the solution is being used in a very special setting, at low temperature, where chemistry behaves differently.
Hydroxyethyl starch is there to help with oncotic pressure. In plain language, it helps keep fluid from leaking too easily into tissues. Heparin is there to reduce clotting. Glutathione is included as an antioxidant, since cold and reoxygenation can create oxidative stress.
There is also debate about insulin. Some people think it may help glucose enter cells under cold conditions. Others think its value is uncertain. That is a real technical argument, not a settled fact.
Where MHP-2 shows up in practice
MHP-2 is used when a patient is washed out after legal death and before deeper preservation steps. In remote cases, this can happen in a transport vehicle, a cooperating funeral home, or another suitable location.
The goal is to replace blood with the perfusate before long cold transport, if the situation allows it. If it cannot be done safely or quickly, teams may skip it rather than delay transport too much.
That tradeoff is part of cryonics reality. A perfect technical step is worthless if it causes the larger process to stall.
This is also why MHP-2 is tied to standby and stabilization. The earlier the team can respond, the more likely blood substitution can happen under controlled conditions.
Why details and quality control matter
The confusion around MHP-2 often comes from treating it like a simple recipe. It is not.
A tiny shift in concentration can change osmolality, pH, and tissue response. A missing buffer, a wrong salt amount, or a component added in the wrong form can change the entire effect.
That is why quality control matters so much. The target numbers are not decoration. They are how teams check whether the mix was made correctly.
Some historical versions of the solution were prepared by proportion. Later practice moved toward defined absolute amounts and direct osmolality checks. That change reflects a practical lesson: if the mix is off, the tissue will notice.
The honest limit
MHP-2 is a procedure tool, not proof of revival. No human cryonics patient has been revived.
What it does show is that cryonics is not one frozen gesture. It is a sequence of technical choices, each one trying to preserve as much structure and function as possible after legal death.
MHP-2 sits at one of those critical points. It is the fluid used when the work turns from emergency response to preservation handling.
That is why the name matters less than the role. It is a cryopreservation procedure because it belongs to the working chain that carries a patient from blood loss, through cold transport, and toward later preservation.
I find that both plain and hard to hold in the same mind. The procedure is concrete. The hope around it is still uncertain.
That is the kind of question The Longer Horizon tries to keep open, with one clear question about cryonics, future preservation, and what hope can honestly mean.
Article by Lea Varga ·